Abstract:The original synthesis of dopamine in the laboratories of H.E. Dale in South London, followed some 50 years later by the seminal mapping of the mesencephalic dopamine (DA) pathways into ramifying mesostriatal, mesolimbic and mesocortical projections, the identification of several DA receptors and their signalling pathways, and the discovery of phasic and tonic modes of dopaminergic activity, have led to important questions about the functions of this modulatory neurotransmitter. The triadic division of these projections has suggested discrete and even parallel functions in movement (eg, Parkinson9s disease, dorsal striatum), reward (eg, drugs of abuse, nucleus accumbens) and cognition (eg, schizophrenia and attention deficit/hyperactivity disorder (ADHD), prefrontal cortex). However, several lines of evidence show that this division to be artificial, it also being important to consider interactions between prefrontal and striatal systems, between the various sectors of the striatum itself, and even its component “direct” and “indirect” pathways. This lecture will provide several examples of how work performed in experimental animals has informed these functional considerations, while also having profound implications for understanding the functions of dopamine in health and disease. A prime example is the discovery that prefrontal cortical dopamine modulates cognitive functions such as working memory, which our own work has suggested to be a consequence of stabilising representations of the world via dopamine D1 receptor actions. This contrasts with findings that striatal dopamine often serves to promote behavioural switching, as occurs for example in Parkinson9s disease, ADHD and stimulant abuse following dopaminergic therapy with l-dopa, methylphenidate, and a D2/3 agonist, respectively. The hypothesis that there exist optimal levels of dopamine activity for efficient cognitive functioning in the prefrontal cortex also has applicability in the sub-cortical brain, based for example on the discovery that optimal titration of dopaminergic therapy for motor function in Parkinson9s disease can lead, not only to cognitive enhancement, but also behavioural dysregulation in certain domains, possibly arising as a consequence of an “over-dosing” of ventral striatal dopamine pathways with probable motivational consequences. Such a motivational role is consonant with the discovery that rewarding effects of psychomotor stimulant drugs such as cocaine and amphetamine were mediated by dopamine-dependent functions of the nucleus accumbens in rats. Recent work has shown that addiction to such drugs is predicted by individual differences in the propensity for impulsive behaviour, associated with variations in dopamine receptor number in the ventral striatum. This impulsivity may reflect an aberrant engagement of pavlovian approach behaviour. However, work in animals has suggested that during the addictive process, there is a shift in control of drug-seeking behaviour from the ventral to dorsal striatum that is consistent with a role for dopamine in stimulus-response habit learning. Implications for recent findings in chronic drug abusers will also be discussed.

Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion

Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls

Constrasting Effects of Dopaminergic Blockade on MDMA and D-Amphetamine Conditioned Taste Aversions

Dopaminergic Enhancement of Striatal Response to Reward in Major Depression

Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence

The Effects of D-Amphetamine, Alpha-Flupenthixol, and Mesolimbic Dopamine Depletion on a Test of Attentional Switching in the Rat

Dopamine and the mechanisms of cognition: Part II. D-amphetamine effects in human subjects performing a selective attention task

Global 5-HT Depletion Attenuates the Ability of Amphetamine to Decrease Impulsive Choice on a Delay-Discounting Task in Rats.

Bilateral Intra-Accumbens Self-Administration of D-Amphetamine: Antagonism with Intra-Accumbens SCH-23390 and Sulpiride.

Enhanced Behavioural Control by Conditioned Reinforcers Following Microinjections of D-Amphetamine into the Nucleus Accumbens

Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers

Novel pharmacokinetic model to estimate dopamine dynamics in humans using PET

Dopaminergic response to graded dopamine concentration elicited by four amphetamine doses.

Time-dependent changes in striatal monoamine levels and gene expression following single and repeated amphetamine administration in rats

Methamphetamine Activates Reward Circuitry in Drug Naïve Human Subjects

An Observational Method for Quantifying the Behavioural Effects of Dopamine Agonists: Contrasting Effects of D-Amphetamine and Apomorphine.

GL.01 Dopamine in Health and Disease

Vitamin D's Capacity to Increase Amphetamine-Induced Dopamine Release in Healthy Humans: A Clinical Translational [11C]-PHNO Positron Emission Tomography Study

Potentiation of the Effects of Reward-Related Stimuli by Dopaminergic-Dependent Mechanisms in the Nucleus Accumbens

Dopamine Release in Dissociable Striatal Subregions Predicts the Different Effects of Oral Methylphenidate on Reversal Learning and Spatial Working Memory

Influence of Compulsivity of Drug Abuse on Dopaminergic Modulation of Attentional Bias in Stimulant Dependence.